You just read:

ARMO BioSciences Presents Data from its Phase 1b Trial in Non-Small Cell Lung Cancer at ESMO Immuno Oncology Congress 2017

News provided by

ARMO BioSciences, Inc.

Dec 09, 2017, 08:00 ET